Asep Medical adopts innovative AI approach to address antibiotic resistance
In a significant announcement at the US Biophysical Society in Philadelphia, Asep Medical Holdings Inc. (CSE: ASEP) (OTCQB: SEPSF) (FSE: JJ8) has shared a breakthrough in the battle against antibiotic resistance and biofilm infections. Dr. Bob Hancock, CEO of Asep Inc., detailed how the company is leveraging artificial intelligence (AI) to develop new, more effective […]